Recursion Pharmaceuticals (RXRX) Free Cash Flow Growth (3y) (2023 - 2026)
Recursion Pharmaceuticals (RXRX) Free Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 24.91% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 20.11% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.71% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Recursion Pharmaceuticals | 1.71 Bn | 1.05 Bn | -6.02 Mn | -3.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.31% |
| Dec 31, 2025 | 12.62% |
| Sep 30, 2025 | -47.07% |
| Jun 30, 2025 | 1.11% |
| Mar 31, 2025 | -56.35% |
| Dec 31, 2024 | -21.16% |
| Sep 30, 2024 | 1.93% |
| Jun 30, 2024 | -77.16% |
| Mar 31, 2024 | -29.50% |
| Dec 31, 2023 | -109.17% |
| Sep 30, 2023 | -56.53% |
| Jun 30, 2023 | -61.28% |
| Mar 31, 2023 | -58.42% |